The form is Injectable vial (5mL, 1.2mg-2mg-2mg-2mg/mL, AOD-9604 6mg + MOTs-C 10mg + Tesamorelin 10mg + Ipamorelin 10mg total)
ALK, ROS1, RET, MET, BRAF fusions/rearrangements) and antibody-based regimens [4], therapeutic options for LUSC remain limited
Then its transported to other locations in the cell and even throughout the body
Therefore, the actual transport mechanism, i.e., symport and/or antiport is a still an open question: it can be speculated that OCTN2 may show different transport features according to isoforms and to the tissue in which it is expressed (Ohashi et al., 1999
39- Crane FL (2001) Biochemical functions of coenzyme Q10